Gero Competitors and Similar CompaniesClear all

Gero's competitors and similar companies include Aqemia, Zentalis Pharmaceuticals and Taiwan Liposome.
Gero
Gero
Gero is a biotechnology company intended to evaluate the personal risks of mortality and health.
Aqemia
Aqemia
Aqemia is a company that develops molecule matching technology.
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals
Zentalis is a biopharmaceutical company.
Taiwan Liposome
Taiwan Liposome
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
Founding Date
Founding Date
2015
Founding Date
2019
Founding Date
2014
Founding Date
1997
Type
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Singapore, SG HQ
Agios Athanasios, CY
Moskva, RU
Locations
Paris, FR HQ
Paris, FR
Locations
New York, US HQ
San Diego, US
Locations
Taipei, TW HQ
港区, JP
Leiden, NL
South San Francisco, US
Employees
Employees
105
Employees
783% increase
Employees
62520% increase
Employees
1652% decrease

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($137.1m) (FY, 2025)
Net income
(NT$983.3m) (FY, 2020)

Funding

Latest funding round
Latest funding round
$ 2.2m (almost 6 years ago)
Latest funding round
$ 1.1m (over 6 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 7.5m
Total funding raised
$ 1.1m
Total funding raised
$ 119m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Aqemia
HQ
Paris, FR
Employees
78↑ 3% increase

Aqemia is a company that develops molecule matching technology.

View company
Zentalis Pharmaceuticals
HQ
New York, US
Employees
62

Zentalis is a biopharmaceutical company.

View company
Taiwan Liposome
HQ
Taipei, TW
Employees
165↓ 2% decrease

Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).

View company